Search Results 451-460 of 2956 for 搜索引擎优化关键字咨询邮箱：lgooxc@hotmail.com

1. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis - Mayo Clinic

   The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...

2. Collaborators - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

   Collaborators. Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer.

3. A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis - Mayo Clinic

   The study proposes to assess whether compared to placebo, CP-690,550 is effective, safe, and tolerable maintenance therapy in subjects with Ulcerative Colitis ( ...

4. Our team - CT Clinical Innovation Center - Mayo Clinic Research

   The CT Clinical Innovation Center at Mayo Clinic has a robust roster of faculty, staff and alumni committed to advancing CT imaging technology and methods ...

5. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

   Also, bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as elotuzumab, can block ...

6. Faculty - Center for Individualized Medicine - Mayo Clinic Research

   Bielinski, Suzette J. Ph.D., M.Ed. Bielinski.Suzette@mayo.edu; Professor of Epidemiology; Publications · Borad, Mitesh J. M.D..

7. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion ...

8. Leif Bergsagel, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher Leif Bergsagel, M.D., studies the molecular pathogenesis of multiple myeloma, which is a tumor of mature, isotype-switched plasma ...

9. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

   This adaptive design study includes a cohort phase and a potential randomization phase. An initial concurrent dosing evaluation will evaluate the safety and ...

10. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to ...